T-MPs were mostly taken up by intestinal epithelial cells (IECs), where they could activate NOD2 and its downstream MAPK and NF-κB, inhibiting the formation of B16 melanoma and CT26 colon cancer in mice. Here, NOD2 is linked to malignant colon neoplasm.